Owing to its strong anti-inflammatory activity through the downregulation of the NF-κB pathway and the restoration of antioxidant capacity via upstream regulation of the Nrf-2 pathway, treatment with nootkatone effectively prevents LPS-induced ALI. Here, NFKB1 is linked to acute respiratory distress syndrome.